Current position

Joel Greenblatt’s Conmed Corp (CNMD) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Gotham Asset ManagementVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ2 2011Earliest verified positive filing snapshot
Latest statusCurrent positionBased on the latest supported relationship state
Peak shares168.45KHighest verified quarter-end share count
Quarters reported46Verified quarters with shares above zero
What happened?

Gotham Asset Management first reported Conmed Corp in Q2 2011. After an earlier exit, the position later appeared again in a verified filing. The reported position was increased and reduced across later filings. Gotham Asset Management currently reports 14.95K shares. The latest verified filing showed: Sold 69.6% of the position.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q2 2026
Sold 69.6% of the position−34.18K shares · 14.95K shares remained
Filing context

Quarter-end price $32.73 · Estimated holding basis $51.47

Q1 2026
Sold 2.4% of the position−1.21K shares · 49.13K shares remained
Filing context

Quarter-end price $35.36 · Estimated holding basis $51.47

Q4 2025
Sold 0.6% of the position−312 shares · 50.35K shares remained
Filing context

Quarter-end price $40.60 · Estimated holding basis $51.47

Q3 2025
Bought 13.9% more+6.16K shares · 50.66K shares reported after the change
Filing context

Quarter-end price $47.03 · Estimated holding basis $51.47

Q2 2025
New position+44.50K shares · 44.50K shares reported
Filing context

Quarter-end price $52.08 · Estimated holding basis $52.08

Q1 2025
Sold the entire position−4.57K shares · No shares reported at quarter-end

1 unchanged quarter is collapsed by default.

Portfolio importance

How important is Conmed Corp in Gotham Asset Management’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Current portfolio weight0.0%Q2 2026
Current rank#1519of 1791 reported positions
Peak portfolio weight0.1%Q1 2012
Best historical rank#186Q1 2012
At peak importanceQ1 2012
CNMD
0.1%
Largest holding
2.3%
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$45.422026-09-18

Market context only; not an investor transaction price.

Latest filing quarter-end price$32.73Q2 2026

Derived from validated reported value and shares where supported.

Estimated holding basis$51.47Historical reference — not actual purchase price

Calculated from supported filing history.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

This tracker follows Gotham Asset Management, LLC’s Form 13F disclosures—not Joel Greenblatt’s personal brokerage account. The filing is firm-level rather than a personal stock list. Form 13F reports quarter-end U.S.-listed positions and certain options, but it does not reveal exact trade dates, execution prices, short positions or the purpose of an option position.